COMPANY
IPSEN BIOPHARMACEUTICALS CANADA INC
IPSEN BIOPHARMACEUTICALS CANADA INC: marketing authorisation holder for Lanreotide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Lanreotide | SOMATULINE AUTOGEL (DIN 02283395), Marketed Regulator Health Canada |
|---|---|
| Lanreotide | SOMATULINE AUTOGEL (DIN 02283409), Marketed Regulator Health Canada |
| Lanreotide | SOMATULINE AUTOGEL (DIN 02283417), Marketed Regulator Health Canada |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.